METHOD OF TREATING CONGENITAL STRUCTURAL MYOPATHIES AND CONGENITAL MUSCULAR DYSTROPHIES BY CORRECTION OF SECONDARY MITOCHONDRIAL CHANGES Russian patent published in 2010 - IPC A61K31/122 A61K31/194 A61K31/205 A61P21/04 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly psychoneurology, and concerns treatment of congenital structural myopathies and muscular dystrophies. That is ensure by the energotropic therapy consisting in the administration of L-carnitine in dosage 20-30 mg/kg/day, coenzyme Q10 in dosage 60-90 mg/day, succinic acid - 200 mg/day, citric acid - 50 mg/kg a day, vitamin B₁ - 100 mg/kg a day, vitamin B₆ - 200 mg a day, vitamin B₁₂ - 200 mg/day for two months two times with an interval of two months.

EFFECT: such complex of drug therapy including the administration of coenzyme Q10 in high dose combined with the developed regimen provides motion activity increase in children suffering structural myopathies and congenital muscular dystrophies due to the integrated effect on various links of mitochondrial exchange.

2 ex, 7 dwg